American Association for Cancer Research (AACR) 2019 – STRO-002 Abstract 3897
American Association for Cancer Research (AACR) 2019
Abstract 3897: Stability and safety evaluation of STRO-002, a site-specific anti-folate receptor alpha antibody-drug conjugate for the potential treatment of ovarian and endometrial cancers.